Tocagen

Tocagen Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of cancer treatment products. It develops gene therapy products for the treatment of primary tumors and metastatic diseases. The company’s products include a prodrug activator candidate for the treatment of glioblastoma multiforme and an immunotherapy candidate for the treatment of metastatic malignant melanoma. Tocagen was founded in 2007 and is headquartered in San Diego, California.